China Anticipates SFDA Approval Of World's First Hep E Vaccine This Year
This article was originally published in PharmAsia News
Executive Summary
China's State FDA is expected to release to the market by the end of the year a locally developed hepatitis E vaccine by Xiamen Innovax Biotech, a commercial arm of Xiamen University.